Midazolam Hydrochloride Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Apr 2, 2020.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-2308-49
Dosage Form
Injection
Presentation
Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2308-49)
Initial Posting
Apr 2, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.